Figure 1.
Survival curve of patients who developed leukopenia in the setting of TMZ exposure. OS curve for patients who developed leukopenia after exposure to TMZ. Median OS was 21 months vs. 14 months. OS, overall survival; TMZ, temozolomide.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.